Phase 3 CATT1 completion of enrollment on track for the third quarter of 2026 Strong balance sheet expected to fund operations through anticipated CATT1 topline data readout HIGH POINT, N.C., May 13 ...
Nephrologists are initiating SGLT2 inhibitors earlier in the chronic kidney disease (CKD) treatment journey and continuing them well below labeled eGFR thresholds. At the same time, real-world uptake ...
Samsung Galaxy Watch can show compatible CGM glucose data today while Samsung works on future non-invasive blood sugar ...
Successfully completed chronic toxicology studies for icovamenib, providing the nonclinical support for advancing to chronic clinical dosing, beyond the 12-week clinical dosing that has been used to ...
This cell therapy Parkinson's program is truly innovative and exemplifies the powerful convergence of exciting academic ...
For healthcare professionals managing long-term care, the weekly weight and vitals routine is no longer just about ticking a documentation box; it's a critical clinical intervention point. As 2026 ...
Research findings are available online in the journal Radiology. The original story “ AI model helps MRI scans predict ...
Blood glucose levels can be a reliable indicator of diabetes risk. But in some populations, it's not enough to catch the ...
Objectives Body mass index (BMI) confers a higher risk of colorectal cancer (CRC) and may influence cancer diagnostic ...
If you have Microsoft Office, consider Microsoft Excel's suite of budgeting templates designed to fit many different needs, ...
MASSIVE UPHEAVAL was the name of the game as the last month yielded a new women’s chart crafted by half... Read More ...
Wall Street remains bullish despite the losses. Analysts rate the stock a Strong Buy, with 14 of 15 analysts recommending purchase and just one rating it a hold. The consensus price target of $49.47 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results